Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact Pricing
Login Book a demo
Vical logo — company profile

Vical

Founded 1987 United States San Diego, United States 242 employees Post-IPO Equity Total: $111.30M Biotechnology

General Information

Company Name Vical
Founded Year 1987
Location United States San Diego, United States
Employees 242
Industries Biotechnology
Funding Stage Post-IPO Equity
Social

BounceWatch is an independent company data service, not affiliated with Vical. To contact Vical, visit vical.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

About Vical

Vical is a biopharmaceutical company founded in 1987, headquartered in San Diego, CA, that focuses on developing products for the prevention and treatment of chronic or life-threatening infectious diseases. The company's cutting-edge approach utilizes patented DNA delivery technologies and other therapeutic methods to push the boundaries of traditional treatments. Vical is at the forefront of pioneering groundbreaking therapies independently and has also formed strategic partnerships with key industry leaders. The company received a $25.00M Post-IPO Equity investment on 08 November 2017. For more information, interested parties can visit www.vical.com.

Taxonomy: biopharmaceuticals, DNA delivery technologies, infectious disease vaccines, animal health products, partnered product development, antifungal, herpes treatment, hepatitis B treatment, invasive fungal infection, San Diego, life-threatening infectious diseases, biopharmaceutical industry, non-viral gene therapy, therapeutic approaches

Funding Rounds & Investors (5)

View All
Funding Stage Amount Investors Lead Investors Date
Post IPO Equity $25.00M -
08 Nov 2017
Post IPO Equity $50.00M -
06 Jan 2012
Post IPO Equity $33.80M -
24 Sep 2010
Venture Round Undisclosed 1
Venrock
Venrock
01 Jan 1992
Venture Round $2.50M 5
Morgenthaler Ventures Sutter Hill Ventures Hilman Ventures
Morgenthaler Ventures, Sutter Hill Ventures +3
29 Sep 1988

Vical Alternatives & Competitors

View All Alternatives
Vical vs
Rampart Bioscience
Rampart Bioscience United States

Leading a new era of effective, safe and accessible gene medicines.

Series A
28 employees
Biopharma, Biotechnology
Vical vs
AusperBio
AusperBio United States

Transforming Patient Lives For a Better Tomorrow

Series B
8 employees
Biopharma, Biotechnology
Vical vs
Anjarium Biosciences AG
Anjarium Biosciences AG Switzerland

DNA to Catalyze Your Advanced Therapies

Series A
15 employees
Biotechnology, Pharmaceutical
View all alternatives

FAQ About Vical

Vical develops biopharmaceutical products for the prevention and treatment of chronic or life-threatening infectious diseases, based on our patented DNA delivery technologies and other therapeutic approaches. Headquartered in San Diego, CA, Vical is independently pioneering the development of par...
Vical was founded in 1987.
Vical is headquartered in San Diego, United States.
Vical operates in Biotechnology. Its work centres on biopharmaceuticals, DNA delivery technologies, infectious disease vaccines and animal health products.
Vical has approximately 242 employees.
Vical has completed 5 funding rounds, raising a total of $111.30M. The latest funding stage is Post-IPO Equity.
Top alternatives and competitors to Vical include Rampart Bioscience, AusperBio, Anjarium Biosciences AG, Oculis, Cormedix Inc.. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Vical and Rampart Bioscience are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for Vical, https://bouncewatch.com/company/vical, updated 30 December 2024. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Book a demo 30 minutes